Clinical Trials · NCT04004988
A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 47
- Start date
- Aug 2019
- Locations
- 1 site, Singapore
- Primary endpoint
- Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) of Tirzepatide From Time Zero to Infinity (AUC0toinf)